Neurodevelopmental and body composition outcomes in children with congenital hypothyroidism treated with high-dose initial replacement and close monitoring

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 9, 2013, Pages 3663-3670

  Albert, Benjamin B ^a   Heather, Natasha ^a   Derraik, José G B ^a   Cutfield, Wayne S ^a,e   Wouldes, Trecia ^b   Tregurtha, Sheryl ^f   Mathai, Sarah ^a   Webster, Dianne ^d   Jefferies, Craig ^f   Gunn, Alistair J ^c   Hofman, Paul L ^a,e  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Departments of Psychological Medicine   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d National Testing Centre   (New Zealand)

^e Gravida: National Centre for Growth and Development   (New Zealand)

^f STARSHIP CHILDREN S HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROXINE;

ANTHROPOMETRY; ARTICLE; BEERY DEVELOPMENTAL TEST OF VISUAL MOTOR INTEGRATION; BODY COMPOSITION; CHILD; CLINICAL ARTICLE; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOVEMENT ASSESSMENT BATTERY FOR CHILDREN; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NERVOUS SYSTEM DEVELOPMENT; NEUROCOGNITIVE ASSESSMENT; NEUROLOGIC EXAMINATION; NEW ZEALAND; OUTCOME ASSESSMENT; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIBLING; WESCHLER INTELLIGENCE SCALE FOR CHILDREN IV; WESCHLER PRESCHOOL AND PRIMARY SCALE OF INTELLIGENCE III;

BODY COMPOSITION; CHILD; CHILD, PRESCHOOL; CONGENITAL HYPOTHYROIDISM; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTELLIGENCE; INTELLIGENCE TESTS; LONGITUDINAL STUDIES; MALE; NEONATAL SCREENING; NEUROPSYCHOLOGICAL TESTS; NEW ZEALAND; PSYCHOMOTOR PERFORMANCE; SEVERITY OF ILLNESS INDEX; THYROID FUNCTION TESTS; THYROXINE;

EID: 84883705403     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1903     Document Type: Article

References (43)

1. Smith DW, Blizzard RM, Wilkins L. The mental prognosis in hypothyroidism of infancy and childhood: a review of 128 cases. Pediatrics. 1957;19:1011-1022.
2. Lowrey G, AsterRH,Carr EA,RamonG, BeierwaltesWH,Spafford NR. Early diagnostic criteria of congenital hypothyroidism: a comprehensive study of forty-nine cretins. AMA J Dis Child. 1958;96: 131-143.
3. Grosse SD, Van Vliet G. Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level? Arch Dis Child. 2011;96:374-379.
4. Oerbeck B, Sundet K, Kase BF, Heyerdahl S. Congenital hypothyroidism: influence of disease severity and L-Thyroxine treatment on intellectual, motor, and school-A ssociated outcomes in young adults. Pediatrics. 2003;112:923-930.
5. Kempers MJE, van der Sluijs Veer L, Nijhuis-van der Sanden RWG, et al. Neonatal screening for congenital hypothyroidism in The Netherlands: cognitive and motor outcome at 10 years of age. J Clin Endocrinol Metab. 2007;92:919-924.
6. Dimitropoulos A, Molinari L, Etter K, et al. Children with congenital hypothyroidism: long-Term intellectual outcome after early highdose treatment. Pediatr Res. 2009;65:242-248.
7. Rovet J. Long-Term neuropsychological sequelae of early-Treated congenital hypothyroidism: effects in adolescence. Acta Paediatr. 1999;88:88-95.
8. Rovet JF. Children with congenital hypothyroidism and their siblings: do they really differ? Pediatrics. 2005;115:e52-e57.
9. Derksen-Lubsen G, Verkerk P. Neuropsychologic development in early treated congenital hypothyroidism: analysis of literature data. Pediatr Res. 1996;39:561-566.
10. Vulsma T, Gons MH, de Vijlder JJM. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med. 1989;321:13-16.
11. Nakamizo M, Toyabe S-I, Asami T, Akazawa K. Mental development of infants with congenital hypothyroidism: a longitudinal study. Clin Pediatr (Phila). 2007;46:53-58.
12. Glorieux J, Desjardins M, Letarte J, Morissette J, Dussault JH. Useful parameters to predict the eventual mental outcome of hypothyroid children. Pediatr Res. 1988;24:6-8.
13. Bongers-Schokking JJ, Koot HM, Wiersma D, Verkerk PH, de Muinck Keizer-Schrama SMPF. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr. 2000;136:292-297.
14. Kreisner E, Schermann L, Camargo-Neto E, Gross JL. Predictors of intellectual outcome in a cohort of Brazilian children with congenital hypothyroidism. Clin Endocrinol (Oxf). 2004;60:250-255.
15. Boileau P, Bain P, Rives S, Toublanc JE. Earlier onset of treatment or increment in LT4 dose in screened congenital hypothyroidism: which was the more important factor for IQ at 7 years? Horm Res. 2004;61:228-233.
16. Selva KA, Harper A, Downs A, Blasco P, Lafranchi S. Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH. J Pediatr. 2005;147:775-780.
17. Rovet JF, Ehrlich RM. Long-Term effects of L-Thyroxine therapy for congenital hypothyroidism. J Pediatr. 1995;126:380-386.
18. Salerno M, Militerni R, Bravaccio C, et al. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism. Thyroid. 2002;12:45-52.
19. Hauri-Hohl A, Dusoczky N, Dimitropoulos A, et al. Impaired neuromotor outcome in school-A ge children with congenital hypothyroidism receiving early high-dose substitution treatment. Pediatr Res. 2011;70:614-618.
20. Jones JH, Gellen B, Paterson WF, Beaton S, DonaldsonMDC.Effect of high versus low initial doses of L-Thyroxine for congenital hypothyroidism on thyroid function and somatic growth. Arch Dis Child. 2008;93:940-944.
21. Dubuis J, Glorieux J, Richer F, Deal C, Dussault J, Van Vliet G. Outcome of severe congenital hypothyroidism: closing the developmental gap with early high dose levothyroxine treatment. J Clin Endocrinol Metab. 1996;81:222-227.
22. Rovet JF, Ehrlich RM, Sorbara DL. Effect of thyroid hormone level on temperament in infants with congenital hypothyroidism detected by screening of neonates. J Pediatr. 1989;114:63-68.
23. Bakker B, Kempers MJE, De Vijlder JJM, et al. Dynamics of the plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism. Clin Endocrinol (Oxf). 2002;57:529-537.
24. Mathai S, CutfieldWS,GunnAJ, et al.Anovel therapeutic paradigm to treat congenital hypothyroidism. Clin Endocrinol (Oxf). 2008; 69:142-147.
25. American Academy of Pediatrics (Rose SR, Section on Endocrinology and Committee on Genetics), American Thyroid Association (Brown RS, Public Health Committee), Lawson Wilkins Pediatric Endocrine Society. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 2006;117:2290-2303.
26. American Academy of Pediatrics Section on Endocrinology and Committee on Genetics, American Thyroid Association Committee on Public Health. Newborn screening for congenital hypothyroidism: recommended guidelines. Pediatrics. 1993;91:1203-1209.
27. Toublanc J, Gruters-Kieslich A, Donaldson M, et al. ESPE Report- revised guidelines for neonatal screening programmes for primary congenital hypothyroidism. Horm Res. 1999;52:49-52.
28. Sun Q, Chen YL, Yu ZB, et al. Long-Term consequences of the early treatment of children with congenital hypothyroidism detected by neonatal screening in Nanjing, China: a 12-year follow-up study. J Trop Pediatr. 2012;58:79-80.
29. Arenz S, Nennstiel-Ratzel U, Wildner M, Dorr H-G, Von Kries R. Intellectual outcome, motor skills and BMI of children with congenital hypothyroidism: a population-based study. Acta Pdiatr. 2008;97:447-450.
30. De Onis M, Habicht JP. Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee. Am J Clin Nutr. 1996;64:650-658.
31. Tanner J, Whitehouse R, Marshall W, Carter B. Prediction of adult height from height, bone age, and occurrence of menarche, at ages 4 to 16 with allowance for midparent height. Arch Dis Child. 1975; 50:14-26.
32. Douglas NM, Dockerty JD. Survival by ethnicity for children diagnosed with cancer in New Zealand during 1990-1993. J Paediatr Child Health. 2007;43:173-177.
33. Salmond C, Crampton P, Atkinson J. NZDep2006 Index of Deprivation. Wellington, New Zealand: Department of Public Health, University of Otago; 2007.
34. Wechsler D. WPPSI-III Australian: Administration and Scoring Manual. New South Wales: Harcourt Assessment; 2004.
35. Wechsler D. WISC-IV Australian Administration and Scoring Manual. Marrickville, New South Wales: Harcourt Assessment; 2003.
36. Beery KE, Buktenica NA, Beery NA. Beery-Buktenica Developmental Test of Visual Motor Integration. Austin, TX: Pro-Ed; 2004.
37. Henderson SE, Sugden DA, Barnett AL. The Movement Assessment Battery for Children-2 Examiner's Manual. London: Harcourt Assessment; 2007.
38. Dunn LM, Dunn DM. Manual: Peabody Picture Vocabulary Test. 4th ed. Bloomington, MN: Pearson Assessment; 2007.
39. Heyerdahl S, Oerbeck B. Congenital hypothyroidism: developmental outcome in relation to levothyroxine treatment variables. Thyroid. 2003;13:1029-1038.
40. Sundet JM, Eriksen W, Tambs K. Intelligence correlations between brothers decrease with increasing age difference evidence for shared environmental effects in young adults. Psychol Sci. 2008;19:843-847.
41. Kempers MJE, van der Sluijs Veer L, Nijhuis-van der SandenMWG, et al. Intellectual and motor development of young adults with congenital hypothyroidism diagnosed by neonatal screening. J Clin Endocrinol Metab. 2006;91:418-424.
42. Imlach-Gunasekara F, Carter K. Persistent low income in New Zealand- children results from longitudinal survey data. N Z Med J. 2012;125:95-100.
43. HackmanDA,Farah MJ, Meaney MJ. Socioeconomic status and the brain: mechanistic insights from human and animal research. Nat Rev Neurosci. 2010;11:651-659.